HBIO icon

Harvard Bioscience
HBIO

Overview Fund Activity

69 hedge funds and large institutions have $66M invested in Harvard Bioscience in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 7 closing their positions.

Holders
69
Holders Change
-1
Holders Change %
-1.43%
% of All Funds
1.73%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
8
Increased
27
Reduced
17
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GPC
1
Glacier Peak Capital
Washington
$3.53M
2
GIM
2
Granahan Investment Management
Massachusetts
$4.69M
3
IAM
3
ICM Asset Management
Washington
$453K
4
FP
4
Foundry Partners
Minnesota
$1.91M
5
BCM
5
Bridgeway Capital Management
Texas
$1.13M

Top Sellers

1
PAMP
1
Polar Asset Management Partners
Ontario, Canada
$0
2
PCMI
2
Paradigm Capital Management Inc
New York
$0
3
HA
3
Heartland Advisors
Wisconsin
$6.1M
4
MOACM
4
Mutual of America Capital Management
New York
$0
5
RA
5
Royce & Associates
New York
$4.62M
Name Market Value Shares Shares
Change 		Shares
Change %
Deutsche Bank
76
Deutsche Bank
Germany
$0 272 +264 +3,300%
1 2 3
4